Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BYBiology

RASSF2 Under the Computational Microscope: Prediction of Destabilizing Missense Variants

  1. 1Department of Biotechnology and Genetic Engineering, , Irbid 22110, Jordan;
  2. 2Department of Anatomy, College of Medicine, , Abha 61421, Saudi Arabia;

Abstract

Background: RASSF2 is a tumor suppressor gene involved in multiple cancers such as colorectal and lung cancer. Different studies have focused on promoter hypermethylation as the main inactivation pathway of this gene, which leads to cancer proliferation and metastasis. Here, using a comprehensive in silico pipeline, we investigate, for the first time, the impact of missense variants on protein structure, stability, and interactions. Methods: Multitiered computational tools were used to predict the most likely pathogenic and destabilizing nsSNPs; the impact of coding mutations on different gene expression was analyzed, and the impact of nsSNPs on PPIs using mCSM-PPI2 and MutPred-PPI was analyzed using predicted AlphaFold protein complexes. Results: Of 454 variants, 19 variants were consistently predicted to be likely pathogenic and destabilizing, 14 variants were in the RA domain, and two variants were in the SARAH domain. V193D, L235P, L247P, and Y275C were conserved and exhibited severe structural and molecular alterations. Also, Y275C was at the interface, and it was predicted to disrupt the RASSF2-MST2 complex. KRT23 and BCL2L14 were significantly downregulated in samples containing mutated RASSF2 in COAD and LUAD, respectively. STRING illustrates the Hippo signaling pathway as the main pathway involved in the network. Conclusions: These findings provide promising candidates that can be important for future functional investigations. However, in vivo and in vitro experiments to validate our findings are necessary.

Related

  1. Compound‐Heterozygous PLVAP Missense Variants Associated With Attenuated Protein‐Losing Enteropathy (DIAR10)
    Jana Zídková, Dagmar Procházková, Petra Konečná +6
    Clinical GeneticsPeer-reviewedCC BY 4.0Full textGenetics & genomicsPMC
  2. HBOCpred: An Ensemble Framework for Prioritisation of Germline Missense Variants in Hereditary Breast and Ovarian Cancer
    Mustafa Tarık Alay, Haktan Bağış Erdem
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Genetics & genomicsCrossref
  3. Molecular characterization and pathogenicity stratification of YWHAG missense variants in developmental and epileptic encephalopathy.
    Wen-Hui Liu, Juan Zhou, Zhong-Yan Zhu +4
    Frontiers in geneticsPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  4. Calibration of AlphaGenome Variant Impact and SpliceAI2 scores as PP3/BP4 evidence for missense, non-coding, and synonymous variants
    A. Babazade, Y. Dolas, T. Duzenli +3
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
  5. BUDDY: An interactive web platform to accelerate the functional modeling of human missense variants using Saccharomyces cerevisiae orthologs
    M. Brown, A. Sriram, J. Garcia +1
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
BibTeX
@article{aleitan2026rassf2,
  title = {{RASSF2 Under the Computational Microscope: Prediction of Destabilizing Missense Variants}},
  author = {Laith Naser AL-Eitan and Mohammad Tareq Abusalem and Mansour Abdullah Alghamdi},
  journal = {Biology},
  year = {2026},
  month = oct,
  doi = {10.3390/biology15201818},
  url = {https://europepmc.org/article/PMC/PMC13701346},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - RASSF2 Under the Computational Microscope: Prediction of Destabilizing Missense Variants
AU  - Laith Naser AL-Eitan
AU  - Mohammad Tareq Abusalem
AU  - Mansour Abdullah Alghamdi
PY  - 2026
DA  - 2026/10/01
JO  - Biology
DO  - 10.3390/biology15201818
UR  - https://europepmc.org/article/PMC/PMC13701346
AB  - Background: RASSF2 is a tumor suppressor gene involved in multiple cancers such as colorectal and lung cancer. Different studies have focused on promoter hypermethylation as the main inactivation pathway of this gene, which leads to cancer proliferation and metastasis. Here, using a comprehensive in silico pipeline, we investigate, for the first time, the impact of missense variants on protein structure, stability, and interactions. Methods: Multitiered computational tools were used to predict the most likely pathogenic and destabilizing nsSNPs; the impact of coding mutations on different gene expression was analyzed, and the impact of nsSNPs on PPIs using mCSM-PPI2 and MutPred-PPI was analyzed using predicted AlphaFold protein complexes. Results: Of 454 variants, 19 variants were consistently predicted to be likely pathogenic and destabilizing, 14 variants were in the RA domain, and two variants were in the SARAH domain. V193D, L235P, L247P, and Y275C were conserved and exhibited severe structural and molecular alterations. Also, Y275C was at the interface, and it was predicted to disrupt the RASSF2-MST2 complex. KRT23 and BCL2L14 were significantly downregulated in samples containing mutated RASSF2 in COAD and LUAD, respectively. STRING illustrates the Hippo signaling pathway as the main pathway involved in the network. Conclusions: These findings provide promising candidates that can be important for future functional investigations. However, in vivo and in vitro experiments to validate our findings are necessary.
SN  - 2079-7737
ER  -